University of West England Adopts HeartSciences MyoVista ECG Platform

Reuters02-05
University of West England Adopts HeartSciences MyoVista ECG Platform

HeartSciences Inc. announced that the University of the West of England (UWE) has adopted the company’s MyoVista Insights™ platform and MyoVista® wavECG™ device as its exclusive ECG technologies. These products will be used to establish an ECG Education and Technology Reference Center at UWE, where they will be integrated into the university’s cardiac and physiological science teaching programs. The agreement aims to support the training of future NHS cardiac scientists and contribute to workforce development in the UK’s cardiac diagnostic sector.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Heartsciences Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9649276-en) on February 05, 2026, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment